Increased Exhaled Nitric Oxide Following Autologous Peripheral Hematopoietic Stem-Cell Transplantation: A Potential Marker of Idiopathic Pneumonia Syndrome

Chest

Volumn 125, Issue 1, 2004, Pages 281-287

  Qureshi, Mohammad A ^a   Girgis, Reda E ^a   Dandapantula, Hari K ^a   Abrams, Judith ^a   Soubani, Ayman O ^a,b  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HARPER UNIVERSITY HOSPITAL   (United States)

Author keywords

Bone marrow transplantation; Exhaled nitric oxide; Idiopathic pneumonia syndrome; Nitric oxide; Peripheral hematopoietic stem cell transplantation; Pulmonary complications; Pulmonary drug toxicity

Indexed keywords

ANTINEOPLASTIC AGENT; CARMUSTINE; CISPLATIN; CYCLOPHOSPHAMIDE;

ADULT; AGED; ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; BREAST CARCINOMA; CANCER CHEMOTHERAPY; CANCER STAGING; CHEMOLUMINESCENCE; CLINICAL ARTICLE; CLINICAL FEATURE; DRUG MEGADOSE; DYSPNEA; EXHALATION; EXPIRATORY FLOW RATE; FEMALE; FOLLOW UP; HUMAN; IDIOPATHIC PNEUMONIA SYNDROME; LUNG DIFFUSION CAPACITY; LUNG FUNCTION; PNEUMONIA; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; VITAL CAPACITY;

EID: 1642534554     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.125.1.281     Document Type: Article

References (45)

1. Soubani AO, Miller KB, Hassoun PM. Pulmonary complications of bone marrow transplantation. Chest 1996; 109:1066-1077
2. Clark JG, Hansen JA, Hertz MI, et al. NHLBI workshop summary: idiopathic pneumonia syndrome after bone marrow transplantation. Am Rev Respir Dis 1993; 147:1601-1606
3. Crawford SW, Hackman RC. Clinical course of idiopathic pneumonia after bone marrow transplantation. Am Rev Respir Dis 1993; 147:1393-1400
4. Cherniack RM, Abrams J, Kalica AR. NHLBI Workshop summary: pulmonary disease associated with breast cancer therapy. Am J Respir Crit Care Med 1994; 150:1169-1173
5. Todd NW, Peters WP, Ost AH, et al. Pulmonary drug toxicity in patients with primary breast cancer treated with high-dose combination chemotherapy and autologous bone marrow transplantation. Am Rev Respir Dis 1993; 147:1264-1270
6. Peters WP, Ross M, Vredenburgh JJ, et al. High-dose chemotherapy and autologous bone marrow support as consolidation after standard-dose adjuvant therapy for high-risk primary breast cancer. J Clin Oncol 1993; 11:1132-1143
7. Bhalla KS, Wilczynski SW, Abushamaa AM, et al. Pulmonary toxicity of induction chemotherapy prior to standard or high-dose chemotherapy with autologous hematopoietic support. Am J Respir Crit Care Med 2000; 161:17-25
8. Wilczynski SW, Erasmus JJ, Petros WP, et al. Delayed pulmonary toxicity syndrome following high-dose chemotherapy and bone marrow transplantation for breast cancer. Am J Respir Crit Care Med 1998; 157:565-573
9. Bhalla KS, Folz RJ. Idiopathic pneumonia syndrome after syngeneic bone marrow transplant in mice. Am J Respir Crit Care Med 2002; 166:1579-1589
10. Haddad IY, Panoskaltsis-Mortari A, Ingbar DH, et al. High levels of peroxynitrite are generated in the lungs of irradiated mice given cyclophosphamide and allogeneic T cells: a potential mechanism of injury after marrow transplantation. Am J Respir Cell Mol Biol 1999; 20:1125-1135
11. Klein JL, Rey PM, Dansey RD, et al. Cardiac sequelae of doxorubicin and paclitaxel as induction chemotherapy prior to high-dose chemotherapy and peripheral blood progenitor cell transplantation in women with high-risk primary or metastatic breast cancer. Bone Marrow Transplant 2000; 20:1047-1052
12. Chandrasekar PH, Abraham OC, Klein J, et al. Low infectious morbidity after intensive chemotherapy and autologous peripheral blood progenitor cell transplantation in the outpatient setting for women with breast cancer. Clin Infect Dis 2001; 32:546-551
13. American Thoracic Society. Recommended standardized procedures for pulmonary testing. Am Rev Respir Dis 1978; 18:55-72
14. American Thoracic Society. Standardization of spirometry, 1987 update. Am Rev Respir Dis 1987; 136:1285-1298
15. Crapo RO, Morris AH, Clayton PD, et al. Lung volumes in healthy nonsmoking adults. Bull Eur Physiopathol Respir 1982; 18:419-425
16. Miller A, Thornton JC, Warshaw R, et al. Single breath diffusing capacity in a representative sample of the population of Michigan, a large industrial state: predicted values, lower limits of normal, and frequencies of abnormality by smoking history. Am Rev Respir Dis 1983; 127:270-277
17. American Thoracic Society. Recommendations for standardized procedures for the on-line and off-line measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide in adults and children, 1999. Am J Respir Crit Care Med 1999; 160:2104-2117
18. Kharitonov SA, Barnes PJ. Exhaled markers of pulmonary disease. Am J Respir Crit Care Med 2001; 163:1693-1722
19. Baraldi E, Azzolin NM, Cracco A, et al. Reference values of exhaled nitric oxide for healthy children 6-15 year old. Pediatr Pulmonol 1999; 27:54-58
20. Lundberg JO, Farkas-Szallasi T, Weitzberg E, et al. High nitric oxide production in human paranasal sinuses. Nat Med 1995; 1:370-373
21. Lundberg JO, Weitzberg E. Nasal nitric oxide in man. Thorax 1999; 54:947-952
22. Borland C, Cox Y, Higenbottam T. Measurement of exhaled nitric oxide in man. Thorax 1993; 48:1160-1162
23. Yates DH, Kharitonov SA, Robbins RA, et al. Effect of a nitric oxide synthase inhibitor and a glucocorticosteroid on exhaled nitric oxide. Am J Respir Crit Care Med 1995; 152:892-896
24. Kharitonov SA, Ching KF, Evans D, et al. Increased exhaled nitric oxide in asthma is mainly derived from the lower respiratory tract. Am J Respir Crit Care Med 1996; 153:1773-1780
25. Massaro AF, Mehta S, Lilly CM, et al. Elevated nitric oxide concentrations in isolated lower airway gas of asthmatic subjects. Am J Respir Crit Care Med 1996; 153:1510-1514
26. Purokivi M, Randell J, Hirvonen MR, et al. Reproducibility of measurements of exhaled NO, and cell count and cytokine concentrations in induced sputum. Eur Respir J 2000; 16: 242-246
27. Girgis RE, Gugnani MK, Abrams J, et al. Partitioning of alveolar and conducting airway nitric oxide in scleroderma lung disease. Am J Respir Crit Care Med 2002: 165:1587-1591
28. Tsoukias NM, George SC. A two-compartment model of pulmonary nitric oxide exchange dynamics. J Appl Physiol 1998; 85:653-666
29. Paredi P, Kharitonov SA, Loukides S, et al. Exhaled nitric oxide is increased in active fibrosing alveolitis. Chest 1999; 115:1352-1356
30. Galley HF, Walker BE, Howdle PD, et al. Regulation of nitric oxide synthase activity in cultured human endothelial cells: effect of antioxidants. Free Radic Biol Med 1996; 21:97-101
31. Adcock IM, Brown CR, Kwon O, et al. Oxidative stress induces NF KB DNA binding and inducible NOS mRNA in human epithelial cells. Biochem Biophys Res Commun 1994; 199:1518-1524
32. Duval DL, Sieg DJ, Billings RE. Regulation of hepatic nitric oxide synthase by reactive oxygen intermediates and glutathione. Arch Biochem Biophys 1995; 316:699-706
33. Gaston B, Drazen JM, Loscalzo J, et al. The biology of nitrogen oxides in the airways. Am J Respir Crit Care Med 1994; 149:538-551
34. Shankar G, Bryson JS, Jennings CD, et al. Idiopathic pneumonia syndrome in mice after allogeneic bone marrow transplantation. Am J Respir Cell Mol Biol 1998; 18:235-242
35. Panoskaltsis-Mortari A, Taylor PA, Yaeger TM, et al. The critical early proinflammatory events associated with idiopathic pneumonia syndrome in irradiated murine allogeneic recipients are due to donor T cell infusion and potentiated by cyclophosphamide. J Clin Invest 1997; 100:1015-1027
36. Wung BS, Cheng JJ, Shyue SK, et al. NO modulates monocyte chemotactic protein-1 expression in endothelial cells under cyclic strain. Arterioscler Thromb Vasc Biol 2001; 21:1941-1947
37. Haddad IY, Pataki G, Hu P, et al. Quantitaten of nitrotyrosine levels in lung sections of patients and animals with acute lung injury. J Clin Invest 1994; 94:2407-2413
38. Kooy NW, Royall JA, Ye YZ, et al. Evidence for in vivo peroxynitrite production in human acute lung injury. Am J Respir Crit Care Med 1995; 151:1250-1254
39. Hickey MJ, Kubes P. Role of nitric oxide in regulation of leukocyte-endothelial cell interactions. Exp Physiol 1997; 82:339-348
40. Massaro AF, Gaston B, Kita D, et al. Expired nitric oxide levels during treatment of acute asthma. Am J Respir Crit Care Med 1995; 152:800-803
41. Perillo IB, Hyde RW, Olszowka AJ, et al. Chemiluminescent measurements of nitric oxide pulmonary diffusing capacity and alveolar production in humans. J Appl Physiol 2001; 91:1931-1934
42. Borland CD, Higenbottam TW. A simultaneous single breath measurement of pulmonary diffusing capacity with nitric oxide and carbon monoxide. Eur Respir J 1989; 2:56-63
43. Nademanee A, Molina A, Fung H, et al. High-dose chemo/ radiotherapy and autologous bone marrow or stem cell transplantation for poor-risk advanced-stage Hodgkin's disease during first partial or complete remission. Biol Blood Marrow Transplant 1999; 5:292-298
44. Stadtmauer EA, O'Neill A, Goldstein LJ, et al. Conventional-dose chemotherapy compared with high-dose chemotherapy plus autologous hematopoietic stem-cell transplantation for metastatic breast cancer. Philadelphia Bone Marrow Transplant Group. N Engl J Med 2000 13; 342:1069-1076
45. McSweeney PA, Nash RA, Sullivan KM, et al. High-dose immunosuppressive therapy for severe systemic sclerosis: initial outcomes. Blood 2002; 100:1602-1610